Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D3 Development, Inc. was a specialized contract development organization (CDO) that provided strategic and operational drug development services to the biotechnology and pharmaceutical industries. Founded by former FDA officials and industry veterans, the company was a pioneer in the "virtual" drug development model, enabling clients to advance therapeutic candidates through clinical trials without the need for extensive internal infrastructure. D3 Development focused on regulatory strategy, clinical trial design, and project management to streamline the path from discovery to market. The company was acquired by PPD (Pharmaceutical Product Development) in 2003 to strengthen its strategic development and consulting capabilities and now operates as part of Thermo Fisher Scientific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D3 Development.